Dr. Andy Bhattacharjee has over 15+ years of experience in Genomics in premier institutions and industry. He has created new businesses, managed projects, developed NEW technologies and authored high-impact peer-reviewed publications. He was Senior Scientist & Strategic Collaborations Manager of Life Sciences Division at Agilent Technologies Inc. (previously Hewlett Packard) prior to Parabase Genomics. His development of a focused sequencing approach earned him and his team the 2008 Agilent Innovation Award for Genomics and contributed to creating Agilent as the technology leader in targeted sequencing products. This work is reflected in his multiple contributions to the development of Agilent’s SureSelect target enrichment assay platform, a standard in Exome Sequencing today. He was also an author (with academic collaborators) of a seminal article on use of Exome Sequencing in medical genomics (with academic collaborators) published in Nature. This work was recognized as Science magazines top biological innovation in 2010. As a post-doctoral fellow at Dana Farber Cancer Institute/Harvard Medical School he developed the first molecular lung cancer classification system. Dr. Bhattacharjee holds a Ph.D. in Molecular Biology from University of Minnesota, a Masters Degree from University of Saskatchewan and bachelor’s degree from Banaras Hindu University.